Please assess the completion status of the following clinical trial:

Trial Title: Prednisolone in Infantile Spasms- High Dose Versus Usual Dose

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~- Children aged 3 months to 2 years presenting with epileptic spasms (at least 1 cluster/day) with EEG evidence of hypsarrhythmia or its variants~Exclusion Criteria:~1. Children with active systemic illness~2. Children with evidence of active tuberculosis~3. Severe Acute Malnutrition ad defined by WHO (visible wasting/Mid Upper Arm Circumference \< 11 cm/pedal edema/Weight for height \< 3 SD)~4. Children with recurrent illness/chronic systemic illness

- Gender: ALL
- Minimum Age: 3 Months
- Maximum Age: 24 Months
- Healthy Volunteers: f

Study Arms:
- High dose (Type: EXPERIMENTAL): Oral Prednisolone will be given at dose of 4 mg/kg/day for 14 days
- Usual dose (Type: ACTIVE_COMPARATOR): Oral prednisolone will be given at dose of 2 mg/kg/day for 14 days

Based on this trial design, predict the completion outcome and termination type (if applicable).